Skip to content

Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation

Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation (PREPARE II Trial)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03787732
Acronym
PREPARE II
Enrollment
1067
Registered
2018-12-26
Start date
2019-02-01
Completion date
2021-06-21
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Intubation Complication, Hypotension on Induction

Keywords

Intubation

Brief summary

Complications are common during tracheal intubation of critically ill patients. Nearly one in five patients undergoing intubation in the intensive care unit experiences cardiovascular collapse, defined as severe hypotension, vasopressor administration, cardiac arrest or death. Cardiovascular collapse during intubation is associated with increased resource utilization and decreased survival. Administration of 500 mL of intravenous crystalloid solution beginning prior to induction may prevent cardiovascular collapse. The only prior trial examining fluid bolus administration during intubation found no effect on cardiovascular collapse or clinical outcomes overall, but a hypothesis-generating subgroup analysis suggested potential benefit to fluid bolus administration among patients receiving positive pressure ventilation between induction and laryngoscopy. Therefore, we propose a randomized trial comparing fluid bolus administration versus none with regard to cardiovascular collapse among critically adults undergoing intubation with positive pressure ventilation between induction and laryngoscopy.

Detailed description

The PREPARE II trial is a prospective, parallel group, pragmatic, randomized trial comparing the effect of a preintubation fluid bolus to no preintubation fluid bolus on the incidence of cardiovascular collapse during and after endotracheal intubation in critically ill adults. Patients admitted to the study units who are deemed by their clinical team to require intubation and fulfill inclusion criteria without meeting exclusion criteria will be randomized 1:1 to receive either an intravenous fluid bolus or no intravenous fluid bolus. All other decisions regarding airway management will remain at the discretion of the treating provider. Conduct of the trial will be overseen by a Data Safety Monitoring Board. An interim analysis will be performed after the enrollment of 375 patients. The analysis of the trial will be conducted in accordance with a pre-specified statistical analysis plan, which will be submitted for publication or made publicly available prior to the conclusion of enrollment. The primary outcome is cardiovascular collapse - a composite endpoint defined as one or more of the following: 1. Death within 1 hour of intubation 2. Cardiac arrest within 1 hour of intubation 3. New systolic blood pressure \< 65 mmHg between induction and 2 minutes after completion of intubation 4. New or increased vasopressor receipt between induction and 2 minutes after completion of intubation The secondary outcome is 28-day in-hospital mortality

Interventions

500 milliliters of an intravenous crystalloid solution of the operator's choosing

OTHERNo Fluid Bolus

No additional intravenous crystalloid administration initiated between randomization and two minutes after completion of endotracheal intubation

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient is undergoing endotracheal intubation in a participating unit 2. Planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit 3. Patient is at least 18 years of age 4. Administration of sedation is planned (with or without neuromuscular blockade) 5. Positive pressure ventilation between induction and laryngoscopy is planned (e.g., non-invasive ventilation or bag-mask ventilation)

Exclusion criteria

1. Prisoners 2. Pregnant patients 3. Urgency of intubation precludes safe performance of study procedures 4. Operator feels administration of a fluid bolus is indicated or contraindicated for the safe performance of the procedure

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular collapse1 hourA composite endpoint defined as one or more of the following * New systolic blood pressure \< 65 mmHg between induction and 2 minutes after intubation * New or increased vasopressor between induction and 2 minutes after intubation * Cardiac arrest within 1 hour of intubation * Death within 1 hour of intubation

Secondary

MeasureTime frame
28-day in-hospital mortality28 days

Other

MeasureTime frameDescription
New or increased vasopressor between induction and 2 minutes after intubationfrom induction to 2 minutes following tracheal intubation
Cardiac arrest within 1 hour of intubation1 hour
Death within 1 hour of intubation1 hour
Lowest systolic blood pressure between induction and 2 minutes after intubationfrom induction to 2 minutes following tracheal intubation
Change in systolic blood pressure from induction to lowest systolic blood pressurebetween induction and 2 minutes following procedure
Ventilator-free days28 days
ICU-free days28 days
Lowest oxygen saturationfrom induction to 2 minutes following tracheal intubationLowest arterial oxygen saturation between induction and 2 minutes after intubation
Incidence of hypoxemiafrom induction to 2 minutes following tracheal intubationIncidence of oxygen saturation \< 90% between induction and 2 minutes after intubation
Incidence of severe hypoxemiafrom induction to 2 minutes following tracheal intubationIncidence of oxygen saturation \< 80% between induction and 2 minutes after intubation
Fraction of inspired oxygen at 24 hours after intubation24 hours
Positive end expiratory pressure at 24 hours after intubation24 hours
Systolic blood pressure at 24 hours after intubation24 hours
Additional intravenous fluids initiated between induction and 2 minutes after intubationfrom induction to 2 minutes following tracheal intubation
Time from induction to successful intubationDuration of procedure (minutes)
Cormack-Lehane grade of glottic view on first attemptDuration of procedure (minutes)
Difficulty of intubationDuration of procedure (minutes)Operator-reported difficulty of intubation on a three-point ordinal scale of: easy, moderate, or difficult.
Incidence of successful intubation on the first laryngoscopy attemptDuration of procedure (minutes)
Number of laryngoscopy attemptsDuration of procedure (minutes)
Need for additional airway equipment or a second operatorDuration of procedure (minutes)
Oxygen saturation at 24 hours after intubation24 hours
New systolic blood pressure < 65 mmHg between induction and 2 minutes after intubationfrom induction to 2 minutes following tracheal intubation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026